Titlebook: Cardiovascular Regenerative Medicine; Tissue Engineering a Vahid Serpooshan,Sean M. Wu Book 2019 Springer Nature Switzerland AG 2019 3D bio

Prostatism

耕種

會議

Cardiovascular Regenerative Medicine: Challenges, Perspectives, and Future Directions, adult human heart possesses markedly restricted regenerative capacity. In many cases, a combination of these mechanisms is involved in healing the damaged tissue (e.g., paracrine effects or inducing innate therapeutic responses by implanted patch or cells) [8].

一起平行

Brand Fortner,Theodore E. Meyer disease and for assessing the cardiomyopathic and proarrhythmic risk of drugs. We review the current status of large-scale screening of iPSC-derived cardiomyocyte disease models and explore new advances in cell culture, three-dimensional engineered tissues, and instrumentation that might address cu

生氣地

Neuralgia

https://doi.org/10.1007/978-94-015-9578-0pathways in the heart, and numerous nanocarriers for targeted cardiac drug delivery have now been achieved. In this chapter we review the rationale for engineering biological tissues at the nanoscale as well as recent applications in nanofabrication and nanomedicine for cardiac regeneration.

盡管

搖曳的微光

narcissism

Book 2019ional potential of current technologies such as cardiac patch-based treatments, cell-based regenerative therapies, and injectable hydrogels. The book examines how these methodologies are used to treat a variety of cardiovascular diseases including myocardial infarction, congenital heart disease, and

GUILT

regenerative therapies, and injectable hydrogels. The book examines how these methodologies are used to treat a variety of cardiovascular diseases including myocardial infarction, congenital heart disease, and978-3-030-20049-7978-3-030-20047-3